ArticleAging cell2026
Multi-Omics Reveals Dysregulated Neurotransmitter Systems in Aging and CNS Disorders.
Article in Aging cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
The neurotransmitter system (NTS) composed of neurotransmitter receptors and transporters is associated with a variety of diseases and disorders. The identification of disease-associated NTS features is important for understanding disease mechanisms and for prioritizing potential therapeutic targets. The differences in the composition of NTS in aging and different diseases are not well understood. Here, we show how to integrate multi-omics data at scale, including single-cell and spatial transcriptomic, to identify disease-associated NTS. By integrating, annotating, and analyzing 368 publicly available single-nucleus RNA sequencing (snRNA-seq) datasets from 17 cohort studies, we created a snRNA-seq dataset for the prefrontal cortex (PFC) of the human brain. The resulting dataset included > 1 million cells covering healthy individuals throughout the life course after birth and eight common neuropsychiatric disorders. We comprehensively describe the cellular heterogeneity of NTS in aging and disease, and resolve the relationship between age or sex and disease-associated NTS. A module composed of NTS and their regulatory genes was constructed and showed disease-associated discriminatory signal, with supportive validation from protein-level and external datasets. In order to screen NTS networks that can simulate disease brain tissue, we conducted a comparative analysis of five disease-related cerebral organoids and found partial similarity between patient-derived organoids and parental brain tissues. Our work provides a multi-disease cell atlas based on large-scale snRNA-seq data and analyses the disease and sex heterogeneity of NTS, which provides new insights into the mechanisms of multiple CNS diseases and sheds light on disease precision therapy against NTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.